El Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC) desarrolla un método para producir serotonina de forma más barata y ecológica a partir de una cepa de levadura vínica
Read moreEn el centro de esta misión se encuentra HealthTAV®, la prueba de medición de telómeros insignia de la empresa basada en su tecnología patentada TAT®, y la prueba complementaria de actividad de ...
Read moreUn equipo del Instituto de Neurociencias de Alicante (IN-CSIC-UMH), centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad Miguel Hernández (UMH), ha desarrollado y...
Read moreIt has been announced today that it they has received “Decision to grant” communications from the Japanese Patent Office (JPO) for two Japanese patent applications related to vafidemstat, Oryzon...
Read moreOryzon Genomics, S.A. announced today that it has received additional “Decision to grant” communications for important patents relating vafidemstat, Oryzon’s LSD1 inhibitor in clinical developme...
Read moreOryzon Genomics announced today that the European Patent Office (EPO) has issued an “intention to grant” communication for Oryzon’s European patent application EP20712565.9 entitled “Methods o...
Read moreOryzon announced today that the European Patent Office (EPO) has now formally granted Oryzon’s European patent EP3661510B1, titled “Methods of treating behavior alterations” related to vafidemst...
Read moreEste compuesto es un derivado sintético lipídico que puede administrarse oralmente, con un perfil de seguridad sobresaliente y que presenta resultados prometedores en pacientes con tumores sólidos ...
Read moreThe technology has the potential to redefine data storage, enhance supply chain security, and open new frontiers in the treatment of complex diseases.
Read moreAlfa Laval and Build to Zero collaborate on a groundbreaking Long Duration Energy Storage (LDES) solution for reducing industrial CO2 emissions
Read moreThis patent protects a novel technology developed by Oryzon to measure the binding of LSD1 inhibitors such as iadademstat or vafidemstat to their therapeutic target, the epigenetic enzyme LSD1 (also k...
Read moreThe trial will evaluate the safety and efficacy of the drug afatinib in patients with Fanconi anemia and locally advanced, unresectable, or metastatic squamous cell carcinoma located in the oral cavit...
Read more